Skip to Content

SQI Diagnostics Inc SQIDF

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

SQI Diagnostics Inc is a Canada-based company engaged in developing and commercializing proprietary technologies & products for multiplexing diagnostics. The company develops multiplexed blood tests to enable simultaneous measurement of molecules like proteins, antibodies, and inflammatory biomarkers. Currently, it is focusing on business units targeting organ transplant, autoimmune disease, and serological testing. Its geographical segments are the United States, Canada, Europe, and the Rest of the World. More than half of the revenue comes from the United States.

Contact
36 Meteor Drive
Toronto, ON, M9W 1A4, Canada
T +1 416 674-9500
Sector Healthcare
Industry Diagnostics & Research
Most Recent Earnings Sep 30, 2020
Fiscal Year End Sep 30, 2021
Stock Type
Employees 42